This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
11-13 November 2025
Congress Center BaselBasel, Switzerland
Menu

Michael Tikhonov
Analytical Group Manager, Oligonucleotides and Peptides at Teva
Speaker

Profile

Michael Tikhonov received a MSc in Chemistry and BSc in Biophysics from Bar Ilan University in 2004. From the year 2006 he has been working for TAPI R&D in small molecules development and since 2020 in Oligonucleotides and Peptides development. He has been involved in many projects during his career from initial development to regulatory submission and post approval activities. Beyond his professional pursuits, he enjoys mountain biking in his leisure time.

Agenda Sessions

  • Challenges of Generic Oligonucleotide Drug Substance Development

    , 16:00
    View Session

At this event

Prev
Next
Sergey Tsukanov, Ph.D.
Senior Director Chemistry
Eli Lilly and Company

See Michael at TIDES Europe: Oligonucleotide and Peptide Therapeutics